License deal in oncolytic virotherapies

The licensed technology, developed by the viral genomics and vaccination unit of Institut Pasteur, is based on changes in the measles viral genome...

€30m for Evotec cancer spin-out

As with the establishment of Topas Therapeutics in 2016, Hamburg-based Evotec is once more pooling various early-stage developmental projects and...

Nabriva receives FDA approval for novel antibiotics

The drug, which will be offered both for intravenous and for oral administration, blocks the peptidyl transferase domain of the ribosome. The drug...

Google maps for tumours and organs

Theoretically, light sheet microscopy can be used i.e. to observe in 3D, which parts of a mouse brain or a whole tumour are penetrated or affected by...

Smart bra set to detect breast cancer

According to the GLOBOCAN database, throughout 2018 breast cancer was the main cause of cancer- related deaths in women worldwide – with a million...

GARDP wants five AMR breakers by 2025

Non profit organisation GARDP (Global Antibiotic Research and Development Partnership) said it wants to collaboratively develop five drugs that break...

Human cell chip predicts chemotherapy effects

Hesperos Inc's reconfigurable "body-on-a-chip" model simultaneously measures compound efficacy and toxicity, for both target cells and...